AstraZeneca PLC
LSE:0A4J
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
LSE:0A4J
|
UK |
|
Aena SME SA
F:A44
|
ES |
|
M
|
Magna International Inc
SWB:MGA
|
CA |
|
AstraZeneca PLC
LSE:AZN
|
UK |
|
C
|
China Science Publishing & Media Ltd
SSE:601858
|
CN |
|
A
|
ASML Holding NV
NASDAQ:ASML
|
NL |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
M
|
Merck & Co Inc
XBER:6MK
|
US |
|
S
|
SMU SA
SGO:SMU
|
CL |
|
W
|
Wynn Resorts Ltd
XHAM:WYR
|
US |
|
I
|
International Business Machines Corp
XMUN:IBM
|
US |
|
R
|
Rockwell Automation Inc
SWB:RWL
|
US |
|
Veeva Systems Inc
NYSE:VEEV
|
US |
|
News Corp
NASDAQ:NWSA
|
US |
|
BlackRock Inc
NYSE:BLK
|
US |
|
Q
|
Qualcomm Inc
XHAM:QCI
|
US |
|
S
|
S&P Global Inc
LSE:0KYY
|
US |
|
W
|
Waste Connections Inc
F:UI51
|
CA |
|
H
|
Hormel Foods Corp
XBER:HO7
|
US |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
New York Times Co
NYSE:NYT
|
US |
|
W
|
Wynn Resorts Ltd
XMUN:WYR
|
US |
|
Amadeus IT Group SA
LSE:0P2W
|
ES |
|
S
|
Standard Bank Group Ltd
XBER:SKC2
|
ZA |
Bankruptcy Probability
AstraZeneca PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AstraZeneca PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
130B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
91B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
89.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
48.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
316.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AstraZeneca PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AstraZeneca PLC has total debt of 29B USD. This includes both short-term (2.9B USD) and long-term (26B USD) debt.
You can find a full breakdown on its Balance Sheet.
